Schedule & Agenda
BIO International Convention
Date
Time
Search Sessions
BIO International Convention
25 Results
Monday, June 13
1:00 PM - 2:35 PM (PDT)

Recombinant protein manufacturing: Lessons to be taken from the emerging cell and gene therapy space
Tech R&D investments are increasingly looking to tackle issues in cell and gene therapy…
Tuesday, June 14
11:00 AM - 11:20 AM (PDT)

The cell and gene therapy market continues to grow rapidly with new molecules entering clinical…
11:20 AM - 11:40 AM (PDT)

Recent years have seen tremendous progress in the application of RNA/DNA based therapeutics, with…
11:40 AM - 12:00 PM (PDT)

The gene therapy industry is fuelled by the desire to expand patient access to these novel, and…
12:00 PM - 12:45 PM (PDT)

Therapeutic Cell and Gene Therapy Modalities - Business and Manufacturing Strategies Impacting the…
12:45 PM - 1:05 PM (PDT)

In recent years, new therapeutic formats with increasing structural complexity, diversity and…
1:05 PM - 1:25 PM (PDT)

While gene therapy remains a relatively new therapeutic modality, expected improvements similar to…
1:45 PM - 2:05 PM (PDT)

Progress in the gene and cell therapy, coupled with positive outcomes of many clinical trials based…
2:05 PM - 2:25 PM (PDT)

As genomic medicine becomes a more and more important modality for treatment of disease,…
2:25 PM - 2:45 PM (PDT)

Drug Discovery programs are empowered with a comprehensive, integrated platform offering high…
2:45 PM - 3:05 PM (PDT)

As a leading CRDMO, WuXi Biologics offers end-to-end solutions to enable global partners to…
3:05 PM - 3:15 PM (PDT)

Interview: Dave Backer Chief Commercial Officer, Oxford Biomedica
3:15 PM - 3:25 PM (PDT)

Interview: Jon Gunther, VP, Business Development, Just – Evotec Biologics
3:25 PM - 3:35 PM (PDT)

Interview: Marieanne De Backer, EVP & Head of Business Development and Licensing
Wednesday, June 15
11:00 AM - 11:20 AM (PDT)

Speed and efficiency remain major drivers for developers bringing their protein-based biologics to…
11:20 AM - 11:40 AM (PDT)

Lentiviral vectors are safe and efficient gene transfer tools for cell therapies and are often…
11:40 AM - 12:00 PM (PDT)

Lentiviral vectors are safe and efficient gene transfer tools for cell therapies and are often…
12:00 PM - 12:45 PM (PDT)

Therapeutic Cell and Gene Therapy Introducing New Technologies to compress timelines, increase…
12:45 PM - 1:05 PM (PDT)

The in-house developed downstream purification system SymphonXTM uses a disposable, generic flow…
1:05 PM - 1:25 PM (PDT)

There is increasing pressure to improve the productivity and efficiency of the drug development…
1:25 PM - 1:45 PM (PDT)

How our Partnerships Move your Life-Changing Biologics to Market: Two Case Studies
Panelists:…
1:45 PM - 2:05 PM (PDT)

You have spent years on research and development, manufactured several process validation lots, and…
2:05 PM - 2:25 PM (PDT)

Cell therapies continue to be blighted by CMC complexities and bottlenecks; Demand for viral vector…
2:25 PM - 2:35 PM (PDT)

Interview: Emmanuel Ligner, President and CEO